Back to
Natixis
GILD
30 quarters
Position history for
Natixis's holdings in Gilead Sciences, Inc.
Yes. Natixis holds 143,928 shares of GILD (Gilead Sciences), worth $18.2M, as of its Q2 2026 13F filing. It reduced the position by 12,787 shares (-8.2%) from Q1 2026. Natixis has held GILD in every 13F on record since Q1 2019, 30 quarterly filings. GILD is 0.1% of Natixis' reported 13F portfolio.
Current Value
$18.2M
Current Shares
143,928
Total Value Change
-$12.1M
Total Shares Change
-330,898
Quarter-by-Quarter History
Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.